STOCK TITAN

[SCHEDULE 13D/A] Medalist Diversified REIT, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Medalist Diversified REIT, Inc. Schedule 13D/A shows that reporting person Kory J. Kramer beneficially owns 41,039 shares of common stock, representing 2.73% of the outstanding shares based on 1,505,270 shares outstanding as of August 11, 2025. The amendment discloses that on August 29, 2025 the Kramerica Trust (for which Mr. Kramer is trustee) agreed to sell 60,000 shares to Francis Kavanaugh for an aggregate purchase price of $750,000, and the Schedule 13D has been updated to reflect that Stock Purchase Agreement and related amendments to Item 4 and Item 6. The filing states Mr. Kramer has sole voting and dispositive power over the 41,039 shares and reports no other transactions in the prior 60 days.

Medalist Diversified REIT, Inc. Il modulo Schedule 13D/A indica che la persona che segnala, Kory J. Kramer, detiene beneficiariamente 41.039 azioni ordinarie, pari al 2,73% del capitale in circolazione, calcolato su 1.505.270 azioni in circolazione al 11 agosto 2025. L'emendamento rivela che il 29 agosto 2025 il Kramerica Trust (di cui il Sig. Kramer è trustee) ha concordato la vendita di 60.000 azioni a Francis Kavanaugh per un prezzo complessivo di $750.000, e lo Schedule 13D è stato aggiornato per riflettere tale Accordo di Acquisto di Azioni e le relative modifiche agli Item 4 e 6. La dichiarazione specifica che il Sig. Kramer ha il pieno potere di voto e di disposizione sulle 41.039 azioni e che non risultano altre operazioni nei 60 giorni precedenti.

Medalist Diversified REIT, Inc. El Schedule 13D/A muestra que la persona informante, Kory J. Kramer, posee beneficiariamente 41.039 acciones ordinarias, lo que representa el 2,73% de las acciones en circulación, basado en 1.505.270 acciones en circulación al 11 de agosto de 2025. La enmienda revela que el 29 de agosto de 2025 el Kramerica Trust (del cual el Sr. Kramer es fideicomisario) acordó vender 60.000 acciones a Francis Kavanaugh por un precio total de $750.000, y el Schedule 13D se ha actualizado para reflejar ese Acuerdo de Compra de Acciones y las enmiendas relacionadas a los Ítems 4 y 6. La presentación indica que el Sr. Kramer tiene el poder exclusivo de voto y de disposición sobre las 41.039 acciones y no reporta otras transacciones en los 60 días previos.

Medalist Diversified REIT, Inc.의 Schedule 13D/A에 따르면 보고자 Kory J. Kramer41,039주의 보통주를 실소유하고 있으며, 이는 2025년 8월 11일 기준 총 1,505,270주 중 2.73%에 해당합니다. 수정보고서는 2025년 8월 29일 Kramer가 수탁자인 Kramerica Trust가 Francis Kavanaugh에게 총 $750,000의 대가로 60,000주를 매도하기로 합의했음을 밝히고 있으며, Schedule 13D는 해당 주식매매계약 및 항목 4와 항목 6에 대한 관련 수정사항을 반영하도록 업데이트되었습니다. 제출서류는 Kramer 씨가 해당 41,039주에 대해 단독 의결권 및 처분권을 보유하고 있으며, 지난 60일 동안 다른 거래는 보고하지 않았다고 명시합니다.

Medalist Diversified REIT, Inc. Le Schedule 13D/A indique que la personne déclarante, Kory J. Kramer, détient bénéficiairement 41 039 actions ordinaires, représentant 2,73% des actions en circulation, sur la base de 1 505 270 actions en circulation au 11 août 2025. L'amendement révèle que le 29 août 2025 le Kramerica Trust (dont M. Kramer est le fiduciaire) a convenu de vendre 60 000 actions à Francis Kavanaugh pour un prix d'achat total de 750 000 $, et que le Schedule 13D a été mis à jour pour refléter cet accord d'achat d'actions ainsi que les modifications des points 4 et 6. le dépôt indique que M. Kramer dispose du pouvoir exclusif de vote et de disposition sur les 41 039 actions et ne rapporte aucune autre transaction au cours des 60 jours précédents.

Medalist Diversified REIT, Inc. Im Schedule 13D/A wird angegeben, dass die meldende Person Kory J. Kramer wirtschaftlich 41.039 Stammaktien besitzt, was 2,73% der ausstehenden Aktien entspricht, basierend auf 1.505.270 ausstehenden Aktien zum 11. August 2025. Die Änderung offenbart, dass der Kramerica Trust (für den Herr Kramer Treuhänder ist) am 29. August 2025 zugestimmt hat, 60.000 Aktien an Francis Kavanaugh für einen Gesamtkaufpreis von $750.000 zu verkaufen, und das Schedule 13D wurde aktualisiert, um diese Aktienkaufvereinbarung und die entsprechenden Änderungen in Punkt 4 und Punkt 6 widerzuspiegeln. Die Einreichung erklärt, dass Herr Kramer die alleinige Stimm- und Verfügungsbefugnis über die 41.039 Aktien hat und in den letzten 60 Tagen keine weiteren Transaktionen meldet.

Positive
  • Clear disclosure of the Stock Purchase Agreement and sale terms (60,000 shares for $750,000)
  • Specific beneficial ownership reported: 41,039 shares, equal to 2.73% of outstanding common stock
  • No legal proceedings disclosed for the reporting person in the past five years
Negative
  • Reduction in trust holdings evidenced by the sale of 60,000 shares (material transfer reported)
  • Limited influence: beneficial ownership of 2.73% suggests the reporting person is not a controlling shareholder

Insights

TL;DR: Reporting person discloses post-transaction beneficial ownership of 2.73% after a trust sale of 60,000 shares for $750,000.

The amendment clarifies a material transfer: the Kramerica Trust sold 60,000 shares to Francis Kavanaugh under a Stock Purchase Agreement dated August 29, 2025, for $750,000. Mr. Kramer still reports sole voting and dispositive power over 41,039 shares (2.73%). The filing is routine for Schedule 13D/A updates and provides required transparency on material changes in ownership and contractual arrangements; it does not include additional contractual rights, joint actors, or litigation disclosures. Impact is limited to ownership disclosure and contract reporting.

TL;DR: Amendment appropriately updates Item 3, Item 4 and Item 6 to reflect a trust stock sale; no governance actions or new arrangements disclosed.

The Schedule 13D/A documents the Stock Purchase Agreement between the Kramerica Trust and Francis Kavanaugh and amends purpose and arrangements sections accordingly. The report confirms Mr. Kramer retains sole control of the shares he beneficially owns and discloses no pending legal or regulatory matters. From a governance perspective, this is a standard disclosure of a change in holdings and a contractual transfer; it does not indicate any change in control, voting agreements, or contested governance matters.

Medalist Diversified REIT, Inc. Il modulo Schedule 13D/A indica che la persona che segnala, Kory J. Kramer, detiene beneficiariamente 41.039 azioni ordinarie, pari al 2,73% del capitale in circolazione, calcolato su 1.505.270 azioni in circolazione al 11 agosto 2025. L'emendamento rivela che il 29 agosto 2025 il Kramerica Trust (di cui il Sig. Kramer è trustee) ha concordato la vendita di 60.000 azioni a Francis Kavanaugh per un prezzo complessivo di $750.000, e lo Schedule 13D è stato aggiornato per riflettere tale Accordo di Acquisto di Azioni e le relative modifiche agli Item 4 e 6. La dichiarazione specifica che il Sig. Kramer ha il pieno potere di voto e di disposizione sulle 41.039 azioni e che non risultano altre operazioni nei 60 giorni precedenti.

Medalist Diversified REIT, Inc. El Schedule 13D/A muestra que la persona informante, Kory J. Kramer, posee beneficiariamente 41.039 acciones ordinarias, lo que representa el 2,73% de las acciones en circulación, basado en 1.505.270 acciones en circulación al 11 de agosto de 2025. La enmienda revela que el 29 de agosto de 2025 el Kramerica Trust (del cual el Sr. Kramer es fideicomisario) acordó vender 60.000 acciones a Francis Kavanaugh por un precio total de $750.000, y el Schedule 13D se ha actualizado para reflejar ese Acuerdo de Compra de Acciones y las enmiendas relacionadas a los Ítems 4 y 6. La presentación indica que el Sr. Kramer tiene el poder exclusivo de voto y de disposición sobre las 41.039 acciones y no reporta otras transacciones en los 60 días previos.

Medalist Diversified REIT, Inc.의 Schedule 13D/A에 따르면 보고자 Kory J. Kramer41,039주의 보통주를 실소유하고 있으며, 이는 2025년 8월 11일 기준 총 1,505,270주 중 2.73%에 해당합니다. 수정보고서는 2025년 8월 29일 Kramer가 수탁자인 Kramerica Trust가 Francis Kavanaugh에게 총 $750,000의 대가로 60,000주를 매도하기로 합의했음을 밝히고 있으며, Schedule 13D는 해당 주식매매계약 및 항목 4와 항목 6에 대한 관련 수정사항을 반영하도록 업데이트되었습니다. 제출서류는 Kramer 씨가 해당 41,039주에 대해 단독 의결권 및 처분권을 보유하고 있으며, 지난 60일 동안 다른 거래는 보고하지 않았다고 명시합니다.

Medalist Diversified REIT, Inc. Le Schedule 13D/A indique que la personne déclarante, Kory J. Kramer, détient bénéficiairement 41 039 actions ordinaires, représentant 2,73% des actions en circulation, sur la base de 1 505 270 actions en circulation au 11 août 2025. L'amendement révèle que le 29 août 2025 le Kramerica Trust (dont M. Kramer est le fiduciaire) a convenu de vendre 60 000 actions à Francis Kavanaugh pour un prix d'achat total de 750 000 $, et que le Schedule 13D a été mis à jour pour refléter cet accord d'achat d'actions ainsi que les modifications des points 4 et 6. le dépôt indique que M. Kramer dispose du pouvoir exclusif de vote et de disposition sur les 41 039 actions et ne rapporte aucune autre transaction au cours des 60 jours précédents.

Medalist Diversified REIT, Inc. Im Schedule 13D/A wird angegeben, dass die meldende Person Kory J. Kramer wirtschaftlich 41.039 Stammaktien besitzt, was 2,73% der ausstehenden Aktien entspricht, basierend auf 1.505.270 ausstehenden Aktien zum 11. August 2025. Die Änderung offenbart, dass der Kramerica Trust (für den Herr Kramer Treuhänder ist) am 29. August 2025 zugestimmt hat, 60.000 Aktien an Francis Kavanaugh für einen Gesamtkaufpreis von $750.000 zu verkaufen, und das Schedule 13D wurde aktualisiert, um diese Aktienkaufvereinbarung und die entsprechenden Änderungen in Punkt 4 und Punkt 6 widerzuspiegeln. Die Einreichung erklärt, dass Herr Kramer die alleinige Stimm- und Verfügungsbefugnis über die 41.039 Aktien hat und in den letzten 60 Tagen keine weiteren Transaktionen meldet.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The percentage of the class was calculated based on 1,505,270 shares of Common Stock outstanding as of August 11, 2025. This Amendment No. 2 to Schedule 13D amends and supplements the statement on Schedule 13D initially filed on January 7, 2025 by Kory J. Kramer, as amended by that certain Amendment No. 1 to Schedule 13D filed on March 24, 2025 (the "Schedule 13D").


SCHEDULE 13D


Kory J. Kramer
Signature:Kory J. Kramer
Name/Title:Kory J. Kramer
Date:09/03/2025

FAQ

What change did the Schedule 13D/A for MDRR report?

The filing amends prior Schedule 13D to disclose that on August 29, 2025 the Kramerica Trust agreed to sell 60,000 shares to Francis Kavanaugh for $750,000 and updates related Items 3, 4 and 6.

How many MDRR shares does Kory J. Kramer beneficially own after the amendment?

The filing states Mr. Kramer beneficially owns 41,039 shares, representing 2.73% of common stock based on 1,505,270 shares outstanding as of August 11, 2025.

Does Mr. Kramer retain voting and dispositive power over his shares of MDRR?

Yes. The filing states he has sole voting power and sole dispositive power over all 41,039 shares reported.

Were any legal proceedings or civil judgments disclosed against the reporting person?

No. The filing states that during the last five years the reporting person has not been convicted in any criminal proceeding and has not been subject to civil proceedings resulting in judgments related to securities laws.

Who purchased the 60,000 shares and for what price?

The buyer is Francis Kavanaugh, who agreed to acquire the shares for an aggregate purchase price of $750,000.
Medalist Diversified Reit Inc

NASDAQ:MDRR

MDRR Rankings

MDRR Latest News

MDRR Latest SEC Filings

MDRR Stock Data

19.44M
805.64k
36.42%
8.67%
0.14%
REIT - Diversified
Real Estate Investment Trusts
Link
United States
Richmond